July 13, 2020 Biopharma takeovers show quantity, if not quality Second-quarter deal values plummeted as Covid-19 spread and the prices of target companies spiralled.
June 26, 2015 Upcoming events: UniQure looks to prove gene therapy and crunch time for Tetraphase’s lead antibiotic
